ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
April 23 2024 - 8:32AM
Business Wire
Tru Niagen® expands to health-conscious Sprouts
consumers in more than 400 locations across 23 states
ChromaDex Corp. (NASDAQ:CDXC), the global authority on
nicotinamide adenine dinucleotide (NAD+) and healthy aging
research, announces that its flagship product, Tru Niagen®, the
number one healthy-aging NAD+ supplement in the United States†, is
now available at Sprouts Farmers Market, marking its inaugural
major grocery debut. As one of the fastest-growing retailers in the
United States, Sprouts Farmers Market now offers Tru Niagen to its
health-conscious consumers in more than 400 locations across 23
states.
“We are privileged to have Sprouts as the first major grocery
chain to carry Tru Niagen,” said Rob Fried, CEO of ChromaDex and
Founder of Tru Niagen. “This partnership advances our mission to
broaden the access of Tru Niagen to a large, health-focused
consumer base and aligns with our vision to help as many people as
possible transform the way they age.”
The sole active ingredient in the clinically proven Tru Niagen
supplement is NIAGEN®, ChromaDex’s patented nicotinamide riboside
(NR) ingredient, the most efficient and superior NAD+ precursor
available. NAD+ is an essential coenzyme that plays a vital role in
cellular processes including mitochondrial function, cellular
energy production, and DNA repair. Embodying the highest scientific
and quality standards, Tru Niagen is backed by two Nobel Prize
winners, 30+ human clinical studies, 300+ published scientific
studies, and has been accepted by the world’s most rigorous
regulatory bodies.
Sprouts Farmers Market is known for its curated selection of
healthy groceries and is a go-to destination for wellness
enthusiasts and those embarking on their health and wellness
journeys. Tru Niagen 300mg 30-count and Tru Niagen Immune bottles
are now available in the women’s section of the dietary supplements
aisle, providing Sprouts customers with easy access to the number
one healthy-aging NAD+ supplement in the United States†.
For more information about the science behind Tru Niagen, please
visit www.truniagen.com. To find a Sprouts store near you, visit
sprouts.com.
About ChromaDex:
ChromaDex Corp. (NASDAQ:CDXC) is the global authority on
nicotinamide adenine dinucleotide (NAD+), with a focus on the
science of healthy aging. The ChromaDex team, comprised of
world-renowned scientists, works with independent investigators
from esteemed universities and research institutions around the
globe to uncover the full potential of NAD+. A vital coenzyme found
in every cell of the human body, NAD+ declines with age and
exposure to other everyday stressors. NAD+ depletion is a
contributor to age-related changes in health and vitality. Setting
the benchmark as the gold standard in scientific rigor, safety,
quality, and transparency, ChromaDex is the innovator behind its
clinically proven flagship ingredient, NIAGEN® (patented
nicotinamide riboside, or NR), the most efficient and
superior-quality NAD+ booster available.
NIAGEN NR is the active ingredient in ChromaDex’s consumer
products, sold as the brand Tru Niagen®, the number one
healthy-aging NAD+ supplement in the United States†. Clinically
proven to increase NAD+ levels, Tru Niagen is helping people around
the world transform the way they age (available at
www.truniagen.com). ChromaDex’s robust patent portfolio protects NR
and other NAD+ precursors. ChromaDex maintains a website at
www.chromadex.com, to which ChromaDex regularly publishes copies of
its press releases, news, and financial information.
†Based on the top-selling dietary supplement brands by revenue
per the largest U.S. e-commerce marketplace (as of
3/1/2023-2/29/2024).
About Sprouts Farmers Market, Inc.:
True to its farm-stand heritage, Sprouts offers a unique grocery
experience featuring an open layout with fresh produce at the heart
of the store. Sprouts inspires wellness naturally with a carefully
curated assortment of better-for-you products paired with
purpose-driven people. The healthy grocer continues to bring the
latest in wholesome, innovative products made with
lifestyle-friendly ingredients such as organic, plant-based and
gluten-free. Headquartered in Phoenix, and one of the largest and
fastest-growing specialty retailers of fresh, natural and organic
food in the United States, Sprouts employs approximately 31,000
team members and operates more than 400 stores in 23 states
nationwide. To learn more about Sprouts, and the good it brings
communities, visit about.sprouts.com.
Forward-Looking Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended, including statements related to whether the partnership
with Sprouts builds upon the Company’s mission to broaden access of
Tru Niagen to a large health-focused consumer base. Statements that
are not a description of historical facts constitute
forward-looking statements and may often, but not always, be
identified by the use of such words as "expects," "anticipates,"
"intends," "estimates," "plans," "potential," "possible,"
"probable," "believes," "seeks," "may," "will," "should," "could"
or the negative of such terms or other similar expressions. Risks
that contribute to the uncertain nature of these forward-looking
statements include the impact of the COVID-19 pandemic on our
business and the global economy; our history of operating losses
and need to obtain additional financing; the growth and
profitability of our product sales; our ability to maintain sales,
marketing and distribution capabilities; changing consumer
perceptions of our products; our reliance on a single or limited
number of third-party suppliers; and the risks and uncertainties
associated with our business and financial condition. More detailed
information about ChromaDex and the risk factors that may affect
the realization of forward-looking statements is set forth in
ChromaDex's Annual Report on Form 10-K for the fiscal year ended
December 31, 2023, ChromaDex's Quarterly Reports on Form 10-Q and
other filings submitted by ChromaDex to the SEC, copies of which
may be obtained from the SEC's website at www.sec.gov. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof, and actual
results may differ materially from those suggested by these
forward-looking statements. All forward-looking statements are
qualified in their entirety by this cautionary statement and
ChromaDex undertakes no obligation to revise or update this release
to reflect events or circumstances after the date hereof.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240423423935/en/
ChromaDex Media Contact: Kendall Knysch, Senior Director
of Media Relations & Partnerships 310-388-6706 ext. 689
kendall.knysch@chromadex.com
ChromaDex Investor Relations Contact: Ben Shamsian Lytham
Partners 646-829-9701 shamsian@lythampartners.com
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From Apr 2024 to May 2024
ChromaDex (NASDAQ:CDXC)
Historical Stock Chart
From May 2023 to May 2024